{"id":20702,"date":"2022-05-26T09:08:39","date_gmt":"2022-05-26T07:08:39","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=20702"},"modified":"2022-05-26T09:08:58","modified_gmt":"2022-05-26T07:08:58","slug":"la-spin-off-surgida-del-idibell-aptadel-therapeutics-recibe-la-ayuda-europea-eurostars","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2022\/05\/la-spin-off-surgida-del-idibell-aptadel-therapeutics-recibe-la-ayuda-europea-eurostars\/","title":{"rendered":"La spin-off surgida del IDIBELL Aptadel Therapeutics recibe la ayuda europea Eurostars"},"content":{"rendered":"
Aptadel Therapeutics ha recibido una beca europea Eurostars<\/strong> para desarrollar la primera terapia dirigida contra el c\u00e1ncer infantil Sarcoma de Ewing, basada en nanopart\u00edculas de ARN.<\/p>\n El Sarcoma de Ewing<\/strong> es un tipo raro de tumor canceroso que crece en los huesos o en los tejidos blandos. Afecta principalmente a ni\u00f1os y j\u00f3venes, pero tambi\u00e9n se observa en adultos. Estos tumores son muy agresivos, tienden a reaparecer y desarrollar met\u00e1stasis despu\u00e9s de la quimioterapia. Se trata del segundo c\u00e1ncer de hueso primario m\u00e1s diagnosticado entre ni\u00f1os y adultos j\u00f3venes. Debido a la carencia de tratamientos efectivos, la supervivencia de los pacientes con sarcoma pedi\u00e1trico que presentan met\u00e1stasis en el momento del diagn\u00f3stico es de apenas el 20%.<\/p>\n Aptadel Therapeutics<\/strong> es una empresa precl\u00ednica cofundada por el IDIBELL enfocada a desarrollar una nueva plataforma de terapia dirigida contra el c\u00e1ncer. Esta plataforma consiste en nanopart\u00edculas cargadas con agentes terap\u00e9uticos, como pueden ser mol\u00e9culas de ARN o f\u00e1rmacos quimioter\u00e1picos, dirigidas a distintos tumores diana. De esta forma los agentes terap\u00e9uticos son liberados s\u00f3lo donde hace falta, evitando as\u00ed efectos secundarios y mejorando la efectividad de las terapias. En concreto, esta ayuda ir\u00e1 dirigida a desarrollar un tratamiento dirigido al receptor EphA2, reduciendo as\u00ed la capacidad de met\u00e1stasis de las c\u00e9lulas cancerosas.<\/p>\n El Dr. \u00d3scar Mart\u00ednez-Tirado<\/strong>, investigador del IDIBELL y cofundador de la spin-off, apunta que: \u00abEstamos muy emocionados de haber recibido una subvenci\u00f3n tan competitiva. El proyecto Eurostars impulsar\u00e1 el desarrollo del primer activo de Aptadel en la cl\u00ednica por tratar el c\u00e1ncer pedi\u00e1trico<\/em>\u00ab.<\/p>\n <\/p>\n <\/p>\n El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L’Hospitalet de Llobregat.<\/em><\/p>\n El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Esta ayuda se destinar\u00e0 a desarrollar un tratamiento dirigido basado en nanopart\u00edculas para el c\u00e1ncer pedi\u00e1trico Sarcoma de Ewing.<\/p>\n","protected":false},"author":8,"featured_media":20703,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[374],"tags":[],"class_list":["post-20702","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacion"],"publishpress_future_action":{"enabled":false,"date":"2025-01-03 13:11:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/20702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=20702"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/20702\/revisions"}],"predecessor-version":[{"id":20704,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/20702\/revisions\/20704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/20703"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=20702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=20702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=20702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}